Skip to main content
Erschienen in: Supportive Care in Cancer 11/2006

01.11.2006 | Short Communication

Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients—single center experience

verfasst von: J. Charvát, Z. Linke, M. Horáèková, J. Prausová

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Aim of work

Evaluation of suitability and safety of venous port implantation with catheter insertion via the right internal jugular vein in oncology patients.

Patients and methods

One hundred one totally implantable venous ports were placed in 100 patients with malignancies from January 1, 2003 until March 31, 2005. Catheter of venous port was preferably inserted via the right internal jugular vein. We recorded a number of successful implantations using this venous approach and the rate of complications during the procedure and follow-up.

Main results

Ninety-seven catheters (96%) of totally implantable venous ports were inserted via the right internal jugular vein in 96 patients, and only in four cases were we not able to access this vein. We had no complications related to catheter insertion via the right internal jugular vein. Follow-up was made in all 96 patients with a total access days of 41 in 151 days (mean: 407 days). Premature catheter removal was required in six (6.2%, 0.144 per 1,000 access days) due to complications: three catheter dislocations/malfunctions (3.1%, 0.072 per 1,000 access days), one port-related sepsis, one pocket port infection, and one decubitus over port (1%, 0.024 per 1,000 access days). Six venous ports were removed after completion of the treatment at the patient’s request.

Conclusion

The placement of totally implantable venous ports with catheter insertion via the right internal jugular vein has a high success rate without any early complications. Follow-up also demonstrates a low incidence of late complications requiring port removal.
Literatur
1.
Zurück zum Zitat Biffi R, deBraud F, Orsi F et al (1998) Totally implantable central venous access port for long-term chemotherapy. A prospective study analyzing complications and cost of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9(7):767–773CrossRefPubMed Biffi R, deBraud F, Orsi F et al (1998) Totally implantable central venous access port for long-term chemotherapy. A prospective study analyzing complications and cost of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9(7):767–773CrossRefPubMed
2.
Zurück zum Zitat Bow EJ, Kilpatrick MG, Clinch JJ (1999) Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: a randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 17(4):1267PubMed Bow EJ, Kilpatrick MG, Clinch JJ (1999) Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: a randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 17(4):1267PubMed
3.
Zurück zum Zitat Broviac JW, Cole JJ, Scribner BH (1973) A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 136(4):602–606PubMed Broviac JW, Cole JJ, Scribner BH (1973) A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 136(4):602–606PubMed
4.
Zurück zum Zitat Carde P, Cosset-Delaigue MF, LaPlanche A, Chareau I (1989) Classical external indwelling central venous catheter versus totally implanted venous access system for chemotherapy administration: a randomized trial in 100 patients with solid tumours. Eur J Clin Oncol 25(6):939–944CrossRef Carde P, Cosset-Delaigue MF, LaPlanche A, Chareau I (1989) Classical external indwelling central venous catheter versus totally implanted venous access system for chemotherapy administration: a randomized trial in 100 patients with solid tumours. Eur J Clin Oncol 25(6):939–944CrossRef
5.
Zurück zum Zitat De Gregorio MA, Miguelena JM, Fernandez JA, De Gregorio C, Tres A, et Alfonso ER (1996) Subcutaneous ports in the radiology suite. An effective and safe procedure for care in cancer patients. Eur Radiol 6(5):748–752CrossRefPubMed De Gregorio MA, Miguelena JM, Fernandez JA, De Gregorio C, Tres A, et Alfonso ER (1996) Subcutaneous ports in the radiology suite. An effective and safe procedure for care in cancer patients. Eur Radiol 6(5):748–752CrossRefPubMed
6.
Zurück zum Zitat Evans TR, Lofts FJ, Mansi JL, Glees JP, Dalgleish AG, Knight MJ (1996) A phase II study of continuous infusion of 5-fluoracil with cisplatin and epirubicin in inoperable cancer. Br J Cancer 73(10):1260–1264PubMed Evans TR, Lofts FJ, Mansi JL, Glees JP, Dalgleish AG, Knight MJ (1996) A phase II study of continuous infusion of 5-fluoracil with cisplatin and epirubicin in inoperable cancer. Br J Cancer 73(10):1260–1264PubMed
7.
Zurück zum Zitat Funaki B, Szymski G, Hackworth C et al (1997) Radiologic placement of subcutaneous infusion chest ports for long-term central venous access. AJR 169(5):1431–1434PubMed Funaki B, Szymski G, Hackworth C et al (1997) Radiologic placement of subcutaneous infusion chest ports for long-term central venous access. AJR 169(5):1431–1434PubMed
8.
Zurück zum Zitat Gyves J, Ensminger W, Niederhuber J et al (1982) Totally implanted system for intravenous chemotherapy in patients with cancer. Am J Med 73(6):840–846CrossRef Gyves J, Ensminger W, Niederhuber J et al (1982) Totally implanted system for intravenous chemotherapy in patients with cancer. Am J Med 73(6):840–846CrossRef
9.
Zurück zum Zitat Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED (1979) A modified right atrial catheter for access to the venous system in marrow transplants recipients. Surg Gynecol Obstet 148(6):871–875PubMed Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED (1979) A modified right atrial catheter for access to the venous system in marrow transplants recipients. Surg Gynecol Obstet 148(6):871–875PubMed
10.
Zurück zum Zitat Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW (1998) Implantable vascular access system. Experience in 1500 patients with totally implanted central venous port system. World J Surg 22(1):12–16CrossRefPubMed Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW (1998) Implantable vascular access system. Experience in 1500 patients with totally implanted central venous port system. World J Surg 22(1):12–16CrossRefPubMed
11.
Zurück zum Zitat Lorenzo JM, Funaki B, Van Ha T, Leef JA (2001) Radiologic placement of implantable chest ports in paediatric patients. Am J Roentgenol 176(4):991–994 Lorenzo JM, Funaki B, Van Ha T, Leef JA (2001) Radiologic placement of implantable chest ports in paediatric patients. Am J Roentgenol 176(4):991–994
12.
Zurück zum Zitat McBride KD, Fisher R, Warnock N, Winfield DA, Read MW, Gaines PA (1997) A comparative analysis of radiological and surgical placement of central venous catheter. CVIR 20(1):17–22CrossRefPubMed McBride KD, Fisher R, Warnock N, Winfield DA, Read MW, Gaines PA (1997) A comparative analysis of radiological and surgical placement of central venous catheter. CVIR 20(1):17–22CrossRefPubMed
13.
Zurück zum Zitat Monreal M, Alastrue A, Rull M et al (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices—prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75(2):251–253PubMed Monreal M, Alastrue A, Rull M et al (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices—prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75(2):251–253PubMed
14.
Zurück zum Zitat Morris SL, Jaques PF, Mauro MA (1992) Radiology assisted placement of implantable subcutaneous infusion ports for long-term venous access. Radiology 184(1):149–151PubMed Morris SL, Jaques PF, Mauro MA (1992) Radiology assisted placement of implantable subcutaneous infusion ports for long-term venous access. Radiology 184(1):149–151PubMed
15.
Zurück zum Zitat O’Neill VJ, Jeffrey Evans TR, Preston J, Moss J, Kaye SB (1999) A retrospective analysis of Hickman line-associated complications in patients with solid tumour undergoing infusion chemotherapy. Acta Oncol 38(8):1103–1107CrossRefPubMed O’Neill VJ, Jeffrey Evans TR, Preston J, Moss J, Kaye SB (1999) A retrospective analysis of Hickman line-associated complications in patients with solid tumour undergoing infusion chemotherapy. Acta Oncol 38(8):1103–1107CrossRefPubMed
16.
Zurück zum Zitat Savader S (2000) Venous interventional radiology. Thieme Medical, New York Savader S (2000) Venous interventional radiology. Thieme Medical, New York
17.
Zurück zum Zitat Shetty PC, Mody MK, Kaston DJ et al (1997) Outcome of 350 implanted chest ports. Results and complications in 161 consecutive patients. J Vasc Interv Radiol 8(6):991–995PubMedCrossRef Shetty PC, Mody MK, Kaston DJ et al (1997) Outcome of 350 implanted chest ports. Results and complications in 161 consecutive patients. J Vasc Interv Radiol 8(6):991–995PubMedCrossRef
18.
Zurück zum Zitat Woda RP, Miner ME, McCandless C, McSweeney TD (1996) The effect of right internal vein cumulation on intracranial pressure. J Neurosurg Anesthesiol 8(4):286–292PubMed Woda RP, Miner ME, McCandless C, McSweeney TD (1996) The effect of right internal vein cumulation on intracranial pressure. J Neurosurg Anesthesiol 8(4):286–292PubMed
19.
Zurück zum Zitat Yip D, Funaki B (2002) Subcutaneous chest ports via the internal jugular vein. Acta Radiol 43(4):371–375CrossRefPubMed Yip D, Funaki B (2002) Subcutaneous chest ports via the internal jugular vein. Acta Radiol 43(4):371–375CrossRefPubMed
Metadaten
Titel
Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients—single center experience
verfasst von
J. Charvát
Z. Linke
M. Horáèková
J. Prausová
Publikationsdatum
01.11.2006
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2006
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0073-2

Weitere Artikel der Ausgabe 11/2006

Supportive Care in Cancer 11/2006 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.